Teva Pharmaceutical Industries | TEVA - Sales Revenues

Stock Price
9,215.00
Daily Change
-55.00 -0.59%
Monthly
1.21%
Yearly
65.83%
Q2 Forecast
8,997.46

Teva Pharmaceutical Industries reported $14.63B in Sales Revenues for its fiscal quarter ending in December of 2025.





Sales Change Date
Aspen Pharmacare ZAR 17.08B 4.32B Dec/2025
Cipla INR 75.18B 710M Dec/2025
Dr.Reddys Laboratories INR 87.27B 780M Dec/2025
Guangzhou Baiy CNY 16.05B 70.52M Dec/2026
Jiangsu Hengrui CNY 8.14B 300M Mar/2026
Kalbe Farma IDR 9.34T 431B Mar/2026
Richter Gedeon HUF 214.69B 26.79B Sep/2025
Sh Fosun Pharma CNY 9.81B 2.35B Mar/2026
Sun Pharmaceuticals INR 147.99B 3.21B Dec/2025
Teva Pharmaceutical Industries USD 14.63B 10M Dec/2025